Objective : Self-expanding stents are increasingly used for the treatment of complex intracranial aneurysms. The purpose of this study was to evaluate the usefulness and safety of a self-expanding nitinol stent (Enterprise) in the treatment of wide-necked intracranial aneurysms.
INTRODUCTION
wide-neck intracranial aneurysms.
MATERIALS AND METHODS
We reviewed the clinical and radiological records in Thirty patients were asymptomatic, four had cerebrovascular accident sequelae, and five had suffered acute subarachnoid hemorrhage. A "wide-necked"
aneurysm was defined as having a neck of > 4 mm diameter or an aspect ratio of > 2.0. Twenty-eight aneurysms were located in the anterior and 12 in the posterior circulation (Table 1) . Thirty-four aneurysms were found incidentally. Seven were dissecting aneurysms. One aneurysm had reopened after prior coil embolization, while 39 had not been treated. All aneurysms were judged impossible to treat using other techniques.
All patients underwent endovascular treatment under general anesthesia. Clopidogrel 300 mg per day was given in the morning of the procedure in patients with unruptured aneurysms. Because of the risk of rebleeding, no premedication with platelet inhibitors was administered to patients with acutely ruptured aneurysms unless thromboembolic events occurred.
Heparin was administered for anticoagulation in a bolus infusion of 4000 IU, followed by 1000 IU/h.
Three neurointerventionalists reviewed the angiographic records. Angiographic results were classified as: complete occlusion (no contrast filling the sac), remnant neck (residual filling of the neck), and remnant sac (residual filling of the sac).
22)
During follow-up, the aneurysm could change from one class to another or remain unchanged. The clinical and angiographic findings are summarized in 
RESULTS

Initial results and complications
Thirty-nine patients with 40 intracranial aneurysms were evaluated. The mean aneurysm neck size was (15%) and a remnant sac was observed in 26/40 (65%) ( Table 2 ). There was one technical complication of coil herniation and four thromboembolic events.
The coil herniation did not cause any morbidity. In two patients, an embolic infarction was seen on dif- One thromboembolic event caused procedure-induced morbidity (2.5%). Among the 39 patients, 29
had an mRS at discharge of 0, four patients had a score of 1, two patients had a score of 3, three patients had a score of 5 and one patient had a score of 6. The four patients with mRS 5 or 6 had suffered subarachnoid hemorrhage. Table 1 stent migration or in-stent thrombosis was observed ( Fig. 1, 2) .
As an alternative, MRA follow-up was used in five treated aneurysms after 10 to 36 months (median, 12 months). No evidence of recurrence was seen in any of these studies (Table 4) . For example, Kadkhodayan et al. 12) reported that the In our study, the immediate angiographic results were disappointing, showing only 20% cases with complete occlusion, 15% with a remnant neck, and 65% with a remnant sac. However, angiographic follow-up showed an improvement, with 72% complete occlusion, 22% remnant neck, and only 6% recanalizations ( Fig. 1, 2) . Thromboembolic complications affecting the clinical outcome occurred in only one case (2.5%). These results are consistent with the pattern reported in a recent large study, 8) and agree with other recent reports that stent-assisted coiling has a favorable long-term outcome. 11)12)14)17) However, Enterprise can cause thromboembolic complications. 12) In the patients who had angiographic follow-up, evidence of stent migration or in-stent thrombosis was not observed. Furthermore, in the cases that had only MRA follow-up, there was no evidence of recurrence.
